Co-Diagnostics Inc.

0.35
-0.01 (-2.78%)
At close: Apr 25, 2025, 2:53 PM

Co-Diagnostics Statistics

Share Statistics

Co-Diagnostics has 33.57M shares outstanding. The number of shares has increased by 2.08% in one year.

Shares Outstanding 33.57M
Shares Change (YoY) 2.08%
Shares Change (QoQ) 0%
Owned by Institutions (%) 18.76%
Shares Floating 30.98M
Failed to Deliver (FTD) Shares 5.57K
FTD / Avg. Volume 2.9%

Short Selling Information

The latest short interest is 162.55K, so 0.51% of the outstanding shares have been sold short.

Short Interest 162.55K
Short % of Shares Out 0.51%
Short % of Float 0.54%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.6 and the forward PE ratio is 3.6. Co-Diagnostics's PEG ratio is -0.18.

PE Ratio -0.6
Forward PE 3.6
PS Ratio 5.81
Forward PS 13.7
PB Ratio 0.42
P/FCF Ratio -0.76
PEG Ratio -0.18
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Co-Diagnostics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.04.

Current Ratio 4.41
Quick Ratio 4.27
Debt / Equity 0.04
Debt / EBITDA -0.06
Debt / FCF -0.07
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $29.66K
Profits Per Employee $-285.14K
Employee Count 132
Asset Turnover 0.06
Inventory Turnover 0.93

Taxes

Income Tax 57.37K
Effective Tax Rate -0.15%

Stock Price Statistics

The stock price has increased by -68.42% in the last 52 weeks. The beta is 1.21, so Co-Diagnostics's price volatility has been higher than the market average.

Beta 1.21
52-Week Price Change -68.42%
50-Day Moving Average 0.46
200-Day Moving Average 0.94
Relative Strength Index (RSI) 44.24
Average Volume (20 Days) 192.11K

Income Statement

In the last 12 months, Co-Diagnostics had revenue of 3.92M and earned -37.64M in profits. Earnings per share was -1.24.

Revenue 3.92M
Gross Profit 2.92M
Operating Income -40.08M
Net Income -37.64M
EBITDA -38.7M
EBIT -40.08M
Earnings Per Share (EPS) -1.24
Full Income Statement

Balance Sheet

The company has 2.94M in cash and 2.15M in debt, giving a net cash position of 784.37K.

Cash & Cash Equivalents 2.94M
Total Debt 2.15M
Net Cash 784.37K
Retained Earnings -33.04M
Total Assets 64M
Working Capital 24.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -29.16M and capital expenditures -748.35K, giving a free cash flow of -29.9M.

Operating Cash Flow -29.16M
Capital Expenditures -748.35K
Free Cash Flow -29.9M
FCF Per Share -0.99
Full Cash Flow Statement

Margins

Gross margin is 74.48%, with operating and profit margins of -1023.75% and -961.37%.

Gross Margin 74.48%
Operating Margin -1023.75%
Pretax Margin -959.9%
Profit Margin -961.37%
EBITDA Margin -988.57%
EBIT Margin -1023.75%
FCF Margin -763.78%

Dividends & Yields

CODX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CODX is $1, which is 177.8% higher than the current price. The consensus rating is "Hold".

Price Target $1
Price Target Difference 177.8%
Analyst Consensus Hold
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -1.52
Piotroski F-Score 2